DAVIS, Calif., March 3, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced today its Venerate™ Bioinsecticide has received federal registration from the EPA. The insecticide controls a broad spectrum of pests and will be sold into a wide variety of crop segments.
Venerate is the first product from the company's in-house discovery screen to be registered. It joins Grandevo® Bioinsecticide in the company's product portfolio that helps growers control crop-damaging pests, while also allowing them to reduce the risk of insects developing resistance to synthetic insecticides.
Dr. Pam Marrone, CEO of MBI, explains how the newly registered product will benefit growers, "With Venerate joining Grandevo in our bioinsecticide lineup, conventional and organic growers will have two biological products—with different modes of action—to strengthen their crop protection programs and reduce the risk of insect resistance."
Dr. Marrone added, "Used either in rotation or in a tank-mix, Venerate can improve the effectiveness of conventional and organic integrated pest management (IPM) programs, and because of its biological profile, it also provides greater flexibility over chemical insecticides that face increasing use restrictions. Venerate also reduces risk to workers, consumers and non-target pests, and carries the same residue level (MRL) exemption, and minimum worker re-entry and pre-harvest intervals as Grandevo, so both products can be used right up to the day of harvest."
Venerate Bioinsecticide is currently being registered in individual states in preparation for the 2014 growing season.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to product features and performance. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the Form 10-Q that the Company filed with the Securities and Exchange Commission on November 8. 2013.
CONTACT: Rich Fedigan Director of Marketing Communications Marrone Bio Innovations 530-750-2800 firstname.lastname@example.org
Source:Marrone Bio Innovations